Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Functional Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04056455
What this trial is testing

Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys

Who this might be right for
Renal ImpairmentHealthy Volunteers
Millennium Pharmaceuticals, Inc. 26
Early research (Phase 1)Study completedNCT02923947
What this trial is testing

Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment

Who this might be right for
Solid Tumours
AstraZeneca 16
Early research (Phase 1)Study completedNCT06908954
What this trial is testing

The Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose

Who this might be right for
Hepatic ImpairmentHealthy
Ipsen 31
Early research (Phase 1)Study completedNCT03259087
What this trial is testing

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 42
Testing effectiveness (Phase 2)Study completedNCT01569828
What this trial is testing

Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

Who this might be right for
PharmacokineticsRenal ImpairedHealthy Volunteer
Novartis Pharmaceuticals 12
Early research (Phase 1)Study completedNCT04699877
What this trial is testing

Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal Function

Who this might be right for
Renal ImpairedGilteritinibNormal Renal Function+1 more
Astellas Pharma Global Development, Inc. 17
Early research (Phase 1)Study completedNCT03865446
What this trial is testing

Evaluate Severe Hepatic Impairment on Dacomitinib PK

Who this might be right for
Severe Hepatic Impairment
Pfizer 16
Post-approval studies (Phase 4)Study completedNCT01896297
What this trial is testing

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 63
Testing effectiveness (Phase 2)Study completedNCT01082640
What this trial is testing

Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment

Who this might be right for
Renal Impairment
Takeda 96
Early research (Phase 1)Study completedNCT05711381
What this trial is testing

Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function

Who this might be right for
Renal Impairment
Hanmi Pharmaceutical Company Limited 16
Early research (Phase 1)Looking for participantsNCT07322016
What this trial is testing

HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hyperlipidemias
Shandong Suncadia Medicine Co., Ltd. 36
Early research (Phase 1)Study completedNCT01764776
What this trial is testing

Effect of Hepatic Impairment on LDE225..

Who this might be right for
Normal Hepatic FunctionImpaired Hepatic Function
Novartis Pharmaceuticals 33
Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Early research (Phase 1)Study completedNCT06911320
What this trial is testing

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Who this might be right for
Healthy Volunteer StudyHepatic ImpairmentRenal Impairment
Atea Pharmaceuticals, Inc. 28
Early research (Phase 1)Looking for participantsNCT07231991
What this trial is testing

Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

Who this might be right for
Healthy Participants
Pfizer 24
Not applicableLooking for participantsNCT06137196
What this trial is testing

Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia

Who this might be right for
AIDSPneumonia
Guangzhou 8th People's Hospital 100
Early research (Phase 1)Study completedNCT01825889
What this trial is testing

Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants

Who this might be right for
Cardiovascular Disease
Eli Lilly and Company 20
Not applicableUnknownNCT04681755
What this trial is testing

Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection

Who this might be right for
Covid19
University Hospital, Strasbourg, France 55
Post-approval studies (Phase 4)Study completedNCT00602290
What this trial is testing

Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression

Who this might be right for
Depression
University of California, Los Angeles 181
Early research (Phase 1)Study completedNCT02210871
What this trial is testing

Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Hepatic Impaired
Novo Nordisk A/S 44
Next Page